Home Blog

Ronald T. Raines, PhD, Joins the Stuart Therapeutics Scientific Advisory Board

Stuart Therapeutics, a pre-clinical stage company developing advanced ophthalmic therapeutics, today announced that Ronald T. Raines, PhD, the Firmenich Professor of Chemistry at the Massachusetts Institute of Technology (MIT), has joined the company’s Scientific Advisory Board. Ronald T. Raines, Ph.D., is an Associate Member of the Broad Institute of MIT and Harvard, and an Affiliate...